Anumana is an AI-driven company that develops ECG algorithms enabling early disease diagnosis and intervention.
Anumana is an AI-driven company that develops ECG algorithms enabling early disease diagnosis and intervention. Anumana harnesses industry-leading AI and translational science to decode the electrocardiogram (ECG) – like a deep predictive tool and biomarker of disease, empowering care providers to help patients early.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 1, 2021 | Series B | $60M | 1 | Nference | — | Detail |
Apr 14, 2021 | Series A | $25.70M | 1 | Nference | — | Detail |